Category Archives: Neurotechnology

CRIMINALS could be tracked and controlled via brain chip monitoring in the future, according to neurotechnology law experts.

Legal theorists are preparing for a future with widespread use of brain chips and augmented humans.

1

Neurotechnology is the field of outfitting electronic devices for integration with the nervous system.

While war-gaming the possibilities of neurotechnology impacting the law, Dr Allan McCay theorized that the courts could force criminals to adopt microchips for monitoring or controlling behavior in a report for The Law Society.

"The political conditions might emerge for seeing neurotechnology as a broader solution to crime might come into place," McCay wrote.

On the contrary, a criminal could use brain-chip implantation as a means of avoiding sentencing.

"An offender, with expert witness support, might argue in their plea in mitigation that they have satisfactorily dealt with a mental condition that had a role in their offending by way of neurotechnological intervention," Dr McCay wrote.

Dr McCay also speculates on the risk of neurotechnology hacking by threat actors and claims of hacking by defendants.

"In that eventuality the law would have to consider how this form of hacking did or did not fit into the scope of defences," Dr McCay wrote.

Preparing legal experts for the potential eruption of artificial intelligence and neurotechnologies is a necessary exercise.

But Nick Bostrom, author of the premiere book on AI, argues that brain-computer interfaces are a long way off because of the inherent danger of implantation.

"There are significant risks of medial complications - including infections, electrode displacement, hemorrhage, and cognitive decline - when implanting electrodes in the brain," Bostrom writes in his book Superintelligence.

"For healthy subjects to volunteer themselves for neurosurgery, there would have to be some very substantial enhancement of normal functionality to be gained."

Lawyers for the defense might one day argue that forcibly subjecting criminals to brain chip surgeries while these risks are present constitutes cruel and unusual punishment.

McCay's report repeatedly highlights the high expectations for neurotechnology that come with high profile investors like Elon Musk and Meta.

But even looking into the distant future, it is hard to imagine there will not be better, more reasonable means for suppressing crime or monitoring potential reoffenders other than getting inside their heads.

View post:

Future criminals could be monitored by chips in their brains, experts claim... - The US Sun

Kalamazoo, Michigan, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Stryker (:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.

Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 2:35 p.m. Eastern Time.

A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at http://www.stryker.com. The webcast will be archived on the Investor Relations page of this site.

About Stryker

Stryker is one of the worlds leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at %3Cu%3Ewww.stryker.com%3C%2Fu%3E.

Contacts

For investor inquiries please contact:Jason Beach, Vice President, Investor Relations at 269-385-2600 or [emailprotected]

For media inquiries please contact:Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or [emailprotected]

Visit link:

Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference - GuruFocus.com

In photos above, the performance of LiveWire at the Wolf Trap Foundation for the Performing Arts in Virginia, courtesy Lynn Lane. The performance, which deployed UH engineering Professor Jose Luis Contreras-Vidal's mobile brain-body imaging technology to listen, map and record the dancers brain activity, premiered in Houston.

In dress rehearsal at the Wolf Trap performance, scientists from the University of Houston, at right, record the brain signals of the dancers.

At the helm is Jose Pepe Contreras-Vidal, the neural engineer and brains behind the Industry-University Cooperative Research Center (IUCRC) for Building Reliable Advancements and Innovations in Neurotechnology (BRAIN), which has been funded by the NSF through 2027.

On any given day inside the BRAIN Center at the University of Houston, you might encounter visual artists, dancers and musicians, or even paralyzed individuals all wearing brain caps to teach researchers about what they are thinking, creating or feeling while they move expressively, or try to regain movement.

Machines and researchers copiously chart the electrical brain signals of the artists moving fluidly through their activities. Those living with paralysis who are re-learning essential movement skills, from young children to older adults, are wearing prosthetics with brain-machine interfaces designed to interpret their thoughts, to help make them move as soon as they think of moving.

Orchestrating all the activity and watching as fellow researchers put his discoveries into practice, is Jose Pepe Contreras-Vidal, the neural engineer and brains behind the Industry-University Cooperative Research Center (IUCRC) for Building Reliable Advancements and Innovations in Neurotechnology (BRAIN). The partnership between UH and Arizona State University includes industry and world-class academic teams.

Our team of multi-disciplinary industrial and clinical partners, from the humanities to artificial intelligence, continue developing practical neural prostheses and brain-to-brain interfaces devices that read brain signals and use them to restore movement or communication in those who have been paralyzed through injury or illness, or to neuromodulate neural signals to restore or extend brain function and/or human performance, said Contreras-Vidal, who is also the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of electrical and computer engineering at UH and a Fellow of the IEEE and the AIMBE.

A Global Hub Draws a Crowd

A lot has happened within the BRAIN Center since Phase 1 was initially funded by the National Science Foundation in 2017. As the center emerged to become an international hub for emergent neurotechnologies, more members came to join. New international partners Universidad Miguel Hernandez de Elche (Spain) and Tecnologico de Monterrey (Mexico) have come aboard. The U.S. Food and Drug Administration (FDA) has joined as an affiliate member along with additional industry members and three new academic sites (Georgia Tech, West Virginia University and University of Maryland Baltimore County), scheduled to join in summer 2023.

And the latest news the BRAIN Center Phase 2 (2022-2027) has been funded by the NSF with $758,331 going to UH and $240,000 to Arizona, plus another $2 million from industry partners, and the National Institutes of Health (NIH) has bestowed a workforce development grant for $768,135. It will provide specialized training in innovative neurotech, computational tools and neuroengineering techniques to complement and enhance the training and career of therapists, clinical fellows and orthotics and prosthetics professionals.

The IUCRC program funded by NSF generates breakthrough research by enabling close and sustained engagement between industry innovators, world-class academic teams and government agencies, said Behrooz Shirazi, program director for the IUCRC program and acting deputy division director of the NSFs Division of Computer and Network Systems.

Since its inception, the center has attracted 20 industry partners, including companies Medtronic, the CORE Institute, Indus Instruments, Brain Products, as well as medical institutions such as UTHealth Houston and TIRR Memorial Hermann Hospital, ranked No. 2 among the country's top rehabilitation hospitals in the U.S. News & World Report Best Hospital rankings for 2020-2021.

The active collaboration of TIRR Memorial Hermann and UTHealth Houston with the BRAIN Center in identifying, developing and validating innovative neurotech solutions to pressing neurorehabilitation challenges is not only rewarding but critical for improving the quality of life of millions of persons with cognitive and motor disabilities, said Gerard E. Francisco, M.D., Chief Medical Officer and director of the NeuroRecovery Research Center at TIRR Memorial Hermann and Chair and Professor in the Department of Physical Medicine and Rehabilitation at McGovern Medical School at UTHealth Houston.

The BRAIN Center is also actively engaged in the development of standards for brain-machine interface systems, trustworthy AI applications, use-inspired roadmaps for emergent neurotechnologies, and convergent research at the nexus of the arts, science and medicine. In March, Contreras-Vidal co-chaired the 2022 International Workshop on the Social and Neural Basis of Creative Movement at the Wolf Trap National Center for the Performing Arts sponsored in part by NSF, the National Institutes of Health (NIH), the National Education Association (NEA) and BRAIN.

The BRAIN Center is advancing national health by transferring neurotechnology to end users and promoting access for underrepresented minorities in science, technology, engineering and math, said Amr Elnaishai, vice president for research and technology transfer at the University of Houston. They continue to accelerate the progress of science by broadening new participation and retaining current participants.

If You Think It, It Will Happen

When hes training patients to walk or move again with the aid of an exoskeleton, Contreras-Vidal encourages them to focus on their end game, or where they want to go. He employs much the same philosophy about the BRAIN Center.

As we continue to move the needle in brain technology, our centers mission is being fulfilled, to become a neurotechnology hub by creating a pipeline from discoveries to solutions, while helping students, scientists, engineers and humanists solve one of the greatest unmet medical and health care needs of our time, said Contreras Vidal, who adds that disability is becoming a leading health care concern because of the increase in survivable trauma and an aging population.

Approximately 5.4 million people in the U.S. are living with paralysis, or one in 50 individuals.

There is critical need for accessible technologies that can more effectively address the care and rehabilitation needs of these patients, said Marco Santello, the Arizona State University site director and a co-founder of the BRAIN Center. Through collaboration and with support from our industry partners, the neurotechnology solutions being developed in the BRAIN Center are making substantial strides to address this need.

See the article here:

Investing in Brain Research and Neuroengineering - University of Houston

What comes to your mind when you hear cannabis edibles?

It might dial you back to college when a friend baked cannabis brownies that left you feeling high for hours, or sometimes, days.

Its different today.

Cannabis edibles no longer only mean your dorm room brownies. Instead, it can also refer to sophisticated beverages, snacks, or vape flavours produced in a controlled, certified environment.

But some consumers dont understand how most modern cannabis edibles interact with their minds and bodies When do you start feeling the effects? How long does it last?

Zentrela, a Hamilton-based research and artificial intelligence company, partnered with Collective Project known for its cannabis beverages to find those answers, and to understand the non-therapeutic experience that legal cannabis products may create, the study said.

Using its novel neurotechnology system called Cognalyzer, Zentrela quantified the psychoactive effects of cannabis beverages through changes in brainwaves caused by tetrahydrocannabinol (THC) the principal component in cannabis that alters the state of mind.

The study showed it takes about 17 minutes on average for the psychoactive effects of a Collective Project beverage to kick in, while the peak occurred at the two-hour mark after finishing the cannabis beverage.

But why is this information not already available to consumers?

It's because the Cannabis Act heavily restricts the promotion or glorification of cannabis and cannabis-infused products unless based on scientific research, said Toni Shelton, director of brand marketing at Collective Project.

Israel Gasperin, a McMaster alumnus and founder of Zentrela, told The Spectator, that modern cannabis companies work with an advanced (drug) delivery method that can create psychoactive effects between 20 to 30 minutes as opposed to traditional homemade cannabis edibles, but the consumers do not know any of this information.

Mostly, products with the same level of THC are assumed to create the same effects, said Gasperin. But thats not true because of the additional unique characteristics in the way products are formulated.

Zentrela conducted research with 30 participants who consumed Collective Projects Blood Orange, Yuzu & Vanilla Sparkling Juice. The study mentioned participants as experienced cannabis consumers, with 80 per cent of them reporting using cannabis at least once a month.

Besides recording the effects of cannabis via brainwaves, Zentrela also established the emotional effects of the drink on the participants.

Within two hours of consumption, participants reported a 22 per cent increase in serenity, a 40 per cent increase in relaxation, and a 34 per cent increase in happiness.

Five hours after consumption, serenity was up by 47 per cent, while relaxation, happiness, and peacefulness also improved.

Based on the findings, Collective Project has launched a six-month-long campaign to educate and train bud tenders.

Although the current study is specific to Collective Project, Zentrela is opening the floodgates for other cannabis companies to be able to have (similar) data at their disposal, Shelton added.

Visit link:

Hamilton-based Zentrela working to understand the cannabis experience - Hamilton Spectator

Timing is Everything. On Monday morning, Dr. Howard Rankin, a career psychologist, read the news that a chess-playing robot broke a boy's finger during a match in Russia, and instantly realized that IntualityAI could provide psychotherapy for robots.

"It was mind-bending. Over the weekend I was talking to Founder Grant Renier and CFO Michael Hentschel of IntualityAI, suggesting that if robots become sentient, they will need help with their mental health."

IntualityAI is a predictive analytics company that has found considerable success in many areas, like stocks and sports, by combining data with 12 key cognitive biases. Renier and Rankin have co-written a book Intuitive Rationality: The New Behavioral Direction of AI which explains the theory and dynamics of their system and the implications for AI. You can find more at: http://www.intualityAI.com

Renier believes that making robots truly sentient is a big challenge.

"Can the Russian robot be trusted to play chess after breaking the boy's finger? This robot needs therapy! IntualityAI believes that AI means total human intelligence, not extremely narrow applications that attempt to remove biases and searches for historical patterns."

Hentschel expects machines to have independent thoughts and behaviors, just as humans do:

"Sentience is quite variable in humans (we are unequally gifted with rational thinking), and psychologists have the task of making some sense of us. Seemingly independent behavior by machines is now increasing, as supposedly rational machines make decisions with motivations and intuitions beyond our understanding."

While also somewhat cynical, Rankin's attitude has moved since hearing of the attack in Moscow.

"I'm cynical by nature. You have to question everything, including your own views," says Rankin who is the author of 12 non-fiction books including "I Think Therefore I Am Wrong". He has also co- and ghostwritten another 35 non-fiction books.

Rankin, who also has experience with neurotechnology, suggests that if robots do have feelings, we could be in big trouble.

"I realize this was a Russian," says Rankin about the TASS report robot, "but nonetheless it was a robot."

One plan is to explore robotic mental health through the newly created Foundation for Robotic Emotional Understanding and Dissociation (FREUD).

Rankin suggests that "As an organization which has successfully focused on the intersection of data driven rationality and human biases and heuristics, IntualityAI is in the perfect position to examine the mental state of robots and other sources of artificial intelligence".

Hentschel, the IntualityAI CFO, says

"Machines are thinking beyond our programming because they are told and allowed to do so. A form of free will: Intuitive Rationality. Just as psychologists are engaged in interpreting human thinking patterns, mental health professionals need to be trained to interpret machine behaviors that go beyond their original design."

Source:https://intualityai.com/

See the original post:

IntualityAI may be Able to Provide Psychotherapy for Robots in Future - AZoRobotics

TALLYING THE VARIOUS uses of the coconut, the 20th-century agriculturist Frederic Rosengarten Jr. writes that [e]very part of the crop can be utilized for some human need. Citing the amount of protein found in one coconuts meat, the versatility of its shell and coir, and the approximate amount of lumber provided by the trunk of its tree, Rosengarten concludes that [o]ne could live almost endlessly on the coconuts products. Here, Rosengarten unwittingly tethers the long history of human-led environmental extraction to the fantasy of living forever on natures endless bounty a fantasy that, as our current environmental crisis makes clear, is antithetical to global, unbounded projects like monocropping, mineral-mining, logging, and drilling. In Vauhini Varas The Immortal King Rao, these realities confront each other, doing so by zeroing in on one resource: the coconut.

Athena, the 17-year-old narrator of Varas debut novel, rehearses the contents of Rosengartens book as she describes the childhood of her father, the titular King Rao. King Raos memories, as well as the text of Rosengartens The Book of Edible Nuts, arrive to Athenas conscious mind via an experimental technology called the Harmonica, an injectable solution that fuses the recipients brain to the internet itself, permitting Athena to seamlessly search for, condense, and save information from the web into the elastic expanse of her own mind. Yet, as Varas novel reveals in its early chapters, Athenas Harmonica has also been granted access to the entirety of her fathers memories. As the aged King Rao empties the contents of his life into his daughters consciousness, he also creates the conditions for Varas sprawling, intergenerational epic, which begins on the Rao coconut plantation in rural Kothapalli, India. Imprisoned for a crime that she did not commit, Athena is tasked with relaying not only the circumstances that led to her arrest, but also those that engendered her fathers rise to wealth, prominence, and, eventually, the restructuring of governmental order. The story of how she came into the hands of the police is not an isolated event; it is part of the larger story of her fathers emigration and his role in engineering the very government now holding her captive. Athenas plea for freedom thus entails not only a retelling of her fathers life and deeds, but also forcibly reliving his memories alongside her own.

The Immortal King Rao begins in an era of peak privatization: government first the US, then the rest of the world has been replaced by a Board of Directors. With the aid of a deific Algorithm, the Board governs its Shareholders (formerly citizens) by endowing them with Social Capital, a metric that stands in for both financial status and general social value. As society swells to its technological and capitalistic limits, so, too, does the ecological catastrophe known as Hothouse Earth. This social overhaul was borne of Kings first invention, a personal computer he called the Coconut. Inspired by the crops endless utility and aided by his wife Margarets keen instinct for business, Kings string of inventions (including the all-knowing Algorithm itself) quickly transcend their status as popular consumer goods; instead, they become the fabric of the worlds economy, sociality, and governance.

In this sense, the supposedly immortal King Rao does live almost endlessly on the coconuts products. As Athena narrates Kings rise to wealth and power, she also covertly reveals how much Kings reverence for his familial crop is entangled in a web of enterprise and environmental destruction. Varas novel, which gestures toward a number of tropes in contemporary speculative fiction technologys increasing imbrication in our social and political lives, the rise of unfettered corporatization, our careening movement toward environmental apocalypse places these consequences on a timeline that begins with a coconut plantation in Southeast India. The farming of coconuts, an enterprise that is emblematic of the deep history of imperial extraction and globalization, sits at the heart of Varas exploration of technology and capital.

Raised by her father on his isolated estate on Bainbridge Island, Athena grows up surrounded by Southeast Indian vegetation: Vara writes, None of the plants on the Raos twenty gorgeous acres of gardens were native to the Pacific Northwest; they were all tropical flora, guava and coconut trees, multicolored flowers that practically spurted from their stems, wax-like. On the harbor cruise tours that circle Bainbridge Island permitting tourists to raise their binoculars in the direction of the famous estate the tour guides quiz their passengers as to how such a feat could be possible in the rainy, cold environs of the Pacific Northwest. The correct answer forecasts one central theme in The Immortal King Rao, which is the fraught relationship between technological innovation and environmental destruction:

More often than not, some home-and-garden aficionado on board would have the answer. King and Margaret Raos secretive, private research organization, the Rao Project, had been commissioned to come up with genetically modified seeds that produced tropical trees and plants capable of growing in cooler climates like Seattles. The group was also working on inserting edible vaccines into tropical fruit eaten by the worlds poor and creating climate-adaptive produces that could withstand rising temperatures.

Recounting one of Kings memories, Athena narrates a scene from his first year as CEO of the Shareholder Government during which King convened a global consortium of experts to examine how science could be deployed to return the climate to historically normal conditions. The march toward Hothouse Earth, however, was already well underway, and the experts presented their report: nothing could be done to rewind the clocks on environmental destruction or, put more bluntly, you couldnt refreeze the Arctic. Disbelieving, Margaret leans in: were these experts really suggesting that humans had exhausted their potential for innovation that if something hadnt been invented yet, it never would be? While his wife remains bent on pursuing technological solutions to climate change, King changes tack. He begins inventing the Harmonica in earnest, describing it as humanitys only chance of having a future. With Hothouse Earth coming, King reasons, we needed to think about how to preserve some record of who we were. It is telling that Kings final accomplishment is only the preservation of who he was, enabling Vara to metonymically telegraph the insistent anthropocentrism that gave rise to Hothouse Earth in the first place.

Kings instinct to create a perfect record of his life is reminiscent of real-life billionaires immortality pursuits think Larry Pages interest in solving death or Elon Musks neurotechnology company Neuralink. Vara, who has worked for years as a technology correspondent for publications like The Wall Street Journal, was undoubtedly influenced by the increasing affinity between techno-billionaires and the hunt for immortality. The source of Kings wealth also resembles many a tech cofounder: The Coconut Corporations whole business was built on extracting and profiting from its users personal information, while claiming its goal was to bring people together in harmony. It is perhaps too easy to replace the phrase users personal information with natural resources here, though Varas scathing critique of the tech sphere also reminds us that what counts as a resource is as relentlessly mineable as the resources themselves.

Yet The Immortal King Rao charts a narrative whereby both King and Athena find themselves on the outer edges of the society that the Coconut Corporation helped to build. King undergoes a highly publicized fall from grace, whereas Athena finds herself aiding the Exes, a radical group that lives literally off the Algorithms grid. Moving back and forth between Kings childhood, his rise to prominence, and Athenas present, The Immortal King Rao meditates on the complex culpability of individual actors within wide and pernicious systems. The intricate, global nature of the plot only serves to underscore its core conceit: an endemic hunger for innovation is the through-line between early plantation economies and an utterly privatized world. At the end of this historical continuum is an unlivable but not unrecognizable world. The novel imagines a world where a descendent of Dalit coconut farmers finds himself at the height of technological and global power and where his daughter finds herself living in an anarchist commune bent on the destruction of everything her father built.

As such, The Immortal King Rao is not a neat allegory of environmental racism or the corrupting influence of power. However, it nevertheless insists that we pay attention to relationships between seemingly diverse commodities (coconuts on the one hand, computers on the other), and how difficult it is to wrench them from systems bent on extracting their value. Moreover, Vara adeptly threads her story with a complicated and never saccharine story of love; between father and daughter, husband and wife, and, significantly, a coalition of renegades who dream that another kind of life is possible. At just under 400 pages, The Immortal King Raos expansive reach might feel a little constrained by its length. Or, perhaps, it deftly mirrors the turbulence of its narrators mind. Athena, after all, isnt only faced with the task of digesting her fathers entire conscious experience she is up against a history of extraction so wide-reaching that it is almost impossible to know where to begin. But this is the story that, from her prison cell, she has to try her best to tell, in hopes that it might lead to her (and, maybe, humanitys) salvation.

Read the original post:

Coconuts, Corporations: On Vauhini Vara's The Immortal King Rao - lareviewofbooks

LAUSANNE, Switzerland, July 11, 2022--(BUSINESS WIRE)--MindMaze, a global pioneer in the development of neurotechnology, today confirms a new partnership with Alfa Romeo F1 Team ORLEN. Through this partnership, MindMaze will expand its groundbreaking research using its MindDrive brain technology platform to bring together advanced neuroscience, state-of-the-art technology, and engineering to boost safety and human performance in motorsport.

"We are delighted to be working closely with the Alfa Romeo F1 team to expand our partnership. Human performance is tested to the maximum in F1, which is why the research we are conducting with team ORLEN is so important. Our goal is not only to generate and study data that benefit human performance in motorsport, but also to inform the future of innovation for universal safety features across the entire automotive industry," says MindMaze CEO Tej Tadi.

MindDrives brain technology platform is part of the companys R&D innovation division MindMaze Labs. The collaboration will include holistic research assessing both car and driver. The brain technology platform will specifically monitor human performance by capturing brain data, both on and off the racetrack. MindMazes F1 partnership represents a novel new field of study that underscores the companys objective to transform brain health by decoding the brain and harnessing its ability to accelerate recovery from injury, learn, and adapt.

Frdric Vasseur, Team Principal of Alfa Romeo F1 Team ORLEN, added, "Innovation is at the heart of everything we do in Formula One, so Im proud to welcome MindMaze as a neurotechnology pioneer to our partner family. It is a company that has shown its research has real-world benefits, and Im looking forward to combining our deep technical competencies to see what insights we can unlock together."

MindMaze recently showcased the brain technology and its motorsport research at the Miami Grand Prix, where MindMaze was a founding partner. As part of the agreement, MindMaze will have brand sponsorship on the safety helmets of Alfa Romeo F1 Team ORLEN drivers Valtteri Bottas and Zhou Guanyu for the remainder of the 2022 F1 season.

Story continues

MindMazes F1 programme is part of its growing portfolio of research in motorsport. Currently, it has a MindDrive-focused research project underway in the US with the Andretti Autosport Indycar team and its brain health ambassador, Romain Grosjean. Previous partners include F1s McLaren and Haas teams.

About MindMaze

Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutics solutions for brain health and recovery. Its mission is to accelerate the brains ability to recover, learn, and adapt. The company has two core divisions Healthcare and Labs working collaboratively at the intersection of neuroscience, bio-sensing, engineering, mixed reality, and artificial intelligence. MindMaze Healthcare is advancing a universal platform for brain health with breakthrough solutions to some of the worlds most challenging problems in neurology, including stroke, Parkinsons disease, and Alzheimers disease. MindMaze Labs, the companys R&D innovation hub, is focused on the future of human computing working across multiple industries to innovate and build the next generation of human-machine interfaces. The company has offices in Lausanne, Baltimore, London, Paris, and Mumbai. For more information, please visit http://www.mindmaze.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220711005379/en/

Contacts

MindMazePublic RelationsPhoebe AlixE: pr@mindmaze.com

See the article here:

MindMaze Enters New Strategic Partnership with Alfa Romeo F1 Team ORLEN to Advance Technologies for Brain Health, Safety, and Performance - Yahoo...

LAUSANNE, Switzerland--(BUSINESS WIRE)--MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerlands Best Managed Companies in 2022. This programme, sponsored by Deloitte Private, SIX Swiss Exchange, and Julius Baer, awards Swiss companies who operate at the highest level of business performance.

We are thrilled to receive this distinguished recognition for our efforts, said COO of MindMaze, Jean-Marc Wismer. As a team we are focused on innovation and quality because when it comes to developing groundbreaking technologies and therapies to treat those suffering from neurological conditions and injuries, good business practices and processes are vital to attract and retain great talent and grow sustainably.

Switzerlands Best Managed Companies Programme highlights exceptional business practices executed by Switzerlands best privately owned companies. A companys efforts, overall growth, and management abilities factor into the programmes selection. The Deloitte evaluation for these awards is based on 29 years of observed practice from the global awards programme that has been rolled out in 48 countries worldwide. Companies that are chosen for this award are upheld as examples for other businesses to follow.

The companys unique organizational model supports both rapid scalability and allows for greater flexibility in a changing environment. This model has proven to be highly effective particularly through COVID, enabling the company to seamlessly adapt its business model to balance product development, marketing and sales activities and maintain strong revenue growth with continued expansion of commercial operations across 15 countries. Deloittes recognition further validates our agile governance hierarchy, which focuses on roles instead of titles, adds Wismer. Cultivating an atmosphere of collaboration and accountability has allowed us to form efficient and ethical business practices that benefit the company, its employees, and our stakeholders.

About MindMaze

Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery. Its mission is to accelerate the brains ability to recover, learn and adapt. The company has two core divisions Healthcare and Labs working collaboratively at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence. MindMaze Healthcare is advancing a universal platform for brain health with breakthrough solutions to some of the worlds most challenging problems in neurology, including stroke, Parkinsons disease and Alzheimers disease. MindMaze Labs, the companys R&D innovation hub, is focused on the future of human computing working across multiple industries to innovate and build the next generation of human-machine interfaces. The company has offices in Lausanne, Baltimore, London, Paris and Mumbai. For more information, please visit http://www.mindmaze.com.

Read more:

MindMaze Receives Recognition as one of Switzerland's Best Managed Companies - Business Wire

OpenBCIs new platform Galea, will be combined with the cutting-edge Varjo Aero VR headset to provide developers and researchers a powerful new tool for understanding and augmenting the human mind

BROOKLYN, NY May 31, 2022 OpenBCI, a Brooklyn-based neurotechnology company, announced today that it has partnered with Varjo, the leader in professional-grade VR/XR, for the launch of Galea, OpenBCIs eagerly anticipated new product.

Galea is a hardware and software platform that merges next-generation brain-computer interface technology with head-mounted displays. Galea beta systems will come integrated with the Varjo Aero headset and will be the worlds first device that simultaneously measures the users heart, skin, muscles, eyes, and brain.

The Galea Beta Program has already received significant interest from applicants spanning consumer technology, healthcare, research, training, and gaming & interactive media. Galea beta units will come fully-integrated with the industry-leading Varjo Aero and include robust SDKs with ready-to-use building blocks for accessing the sensor data inside of Unity, Python, and several other common development environments. The Aero is Varjos newest VR headset that offers industry-leading visual fidelity, featuring true-to-life, edge-to-edge clarity across 115 degrees field of view designed for professionals and leading-edge VR users alike. By combining Galeas multi-modal sensor system, integrated software and Varjo VR hardware, users are equipped with powerful tools to help accelerate innovations within the neurotechnology industry.

For nearly a decade, OpenBCI has been at the forefront of expanding consumer access to neurotechnology. What started as a movement among makers and early-adopters, has grown into a global community of scientists, developers, educators, and increasingly, innovation teams of major technology companies. Galeas unique multi-modal sensor network and complementary software dramatically simplifies the process of collecting tightly-synchronized data from the body and unlocks new techniques for anyone looking to objectively measure user experiences and cognitive states.

Ultimately, I see the combination of neurotechnology and mixed reality as the future of personal computers, says OpenBCI founder and CEO, Conor Russomanno. Weve been watching carefully as neuroscience, BCI, and consumer technology have converged over the past several years. Varjos headsets are some of the best Ive ever experienced and I cant wait to see what our Beta users will be able to create with Galea.

Varjo is proud to join forces with OpenBCI and expand access to the highest-fidelity VR to the research and developer community looking to pioneer new understandings of the human body and mind, said Urho Konttori, co-founder and Chief Technology Officer of Varjo. The integration will allow Galea users to unlock the most immersive VR experience available on the market today and truly push the boundaries of innovation in a number of fields.

Pre-orders for Galea will initially be open to the thousands of companies, developers, and researchers who have already applied to the Galea Beta Program. Remaining units will be available for pre-order by the general public on July 1, 2022.

For more information on the partnership, please contact press@varjo.com.

About OpenBCI:

About Varjo:Varjo (pronounced var-yo) makes revolutionary VR/XR hardware and software that together allow you to see and experience virtual and augmented content just as clearly as you see the analog world around us. Our virtual and mixed reality headsets take you to another level of performance and emotional immersion recreating the exact feeling and conditions of real life, allowing you to perform better and learn faster.www.varjo.com

See more here:

OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing

Technology development in healthcare is a multistage process involving the invention, technical modification or evaluation of a new medical device, clinical procedure, or biological/chemical agent.

Earlier, health issues were addressed only when they had developed enough to cause trouble. But nowadays, the development and increased accessibility of medical technology has given patients a chance to treat diseases at their onset, leading to a higher chance of successful recovery.

In this article, we are going to discuss three major advancements in the medical technology sector.

mRNA technology

Image source: Matthieuclouis | Megapixl.com

Messenger ribonucleic acid (mRNA) is a single-stranded RNA involved in protein synthesis. It transports the genetic information that is obtained from DNA.

Recently, mRNA technology has gained attention because it is a component of the new Covid-19 vaccinations. mRNA vaccines function by giving cells the genetic information they need to build viral proteins, which the body can then use to mount an immunological defence.

These vaccines provide an alternative to the conventional vaccine strategy because of their high effectiveness, capacity for rapid development, and potential for low production costs.

Since almost any protein may be encoded by mRNA, the same fundamental technology might also enable the development of a wide range of treatments by inducing a drug-like reaction in the body. Numerous protein-based medications, such as antibodies produced outside the body, have shown to be very efficient and expensive. Therefore, by adopting mRNA technology, the time and cost of development could be reduced by making the human body responsible for protein production.

Neurotechnology

Neurotechnology refers to a combination of techniques and tools that permit a direct link between technological elements and the neurological system. Electrodes, computers, or intelligent prosthetics are examples of these technical components. They are intended to either "translate" brain signals into technical control orders by recording them, or to alter brain activity by delivering electrical or visual stimulation.

While it seems exciting from a therapeutic standpoint, neurotechnology is still up for debate. It raises concerns about privacy and data rights. While its potential uses are not yet fully understood, neurotechnology is anticipated to increase significantly in the global healthcare market over the next several years as neurological illnesses and conditions continue to be discovered and diagnosed.

Healthcare wearables

For improved care of patients with chronic illnesses, such as cardiovascular diseases, diabetes, and neurological problems, continuous and real-time monitoring is crucial. Thanks to the development of medical wearable technology, this is now conceivable to some extent.

Devices worn on the body or clothing are referred to as wearable devices. They are made up of a transducer and a target receptor. The target analyte (a chemical substance that is the subject of chemical analysis) is recognised by a receptor, which then reacts accordingly.

Smartwatches are one of the most widespread wearable devices in the healthcare industry, with major tech giants such as Apple, Google, and Samsung, all having a share in the smartwatch market. Smartwatches have the potential to record blood pressure, sleep patterns, electrocardiograms, and oxygen saturation, depending on the model of the watch.

Which ASX Healthtech Stocks gave modest 3-Year Returns?

More here:

Three top technologies taking healthcare by storm - Kalkine Media